Matrix Laboratories
BSE: 524794|NSE: MATRIXLABS|ISIN: INE604D01023|SECTOR: Pharmaceuticals
Matrix Laboratories is not traded in the last 30 days
Matrix Laboratories is not traded in the last 30 days
- Quote
- CHARTS
- NEWS
- COMMENTS
- ANNOUNCEMENTS
- CORPORATE ACTION
- FINANCIALS
- ANNUAL REPORT
- SHAREHOLDING
- PEERS
- COMPANY INFO
- ALERTS
- Widgets
- BROKER
RESEARCH
Track Matrix Lab on the go with the moneycontrol app
Company History - Matrix Laboratories | |
Herren Drugs & Pharmaceuticals Limited was incorporated as a private limited company on November 29, 1984 and was subsequently converted to a public limited company on August 29, 1992 for the manufacture of bulk drugs. The company commenced its commercial production in October, 1989 with an installed capacity of 72 TPA and has increased its capacity to 252 TPA in Sept, 1993 and has been involved in the production of Ibuprofen, Sulphamethoxazole (SMX), Norfoxacin and Pefloxacin. SUBSIDIARY OF THE COMPANY The Company does not have any subsidiaries. GROUP PROFILE HERREN DRUGS & PHARMACEUTICALS LIMITED is the flagship company of the Herren Group, founded by Mr.Sarat Gopal. Besides Herren Drugs a Pharmaceuticals Ltd., Mr.Sarat Gopal has also successfully promoted four other Bulk Drug and Intermediate manufacturing units, M/s.Dolphin Drugs (P) Ltd., United Intermediaries & Chemicals (P) Limited, Dymes Engineers (P) Limited and M/s.Dymes Exports Ltd. The Group owes its success and growth largely to its Promoters for their dynamic vision and total dedication. With a modest turnover of Rs.25.00 lakhs in the year 1989-90 the Group has enjoyed a steady growth resulting in a total turnover of Rs.25.00 crores for the year ended 31st March 1994. 2002 -N Prasad appointed as MD of Matrix Lab. -Matrix Lab and Medicorp form a strategic alliance to establish a strong presence in the Global Active Pharmaceutical Ingredient. 2003 -Matrix Laboratories announces the change in the designation of whole time directors: 1. Mr.M Ravinder as Executive Vice-President. 2. Mr R Sundara Rajan as Executive Vice-President. -Matrix Laboratories completes merger of Vorin Labs and Medicorp India with it. -Matrix Lab receives approval from US Food and Drug Administrations for fluconazole Active Pharmaceutical Ingredient. -Matrix Lab submits application for drug master files for seven of the company produts in the US markets. -Lundbeck withdraws allegations of Forgery made against Matrix Laboratories -Signed agreement with William J Clinton Presidential Foundation for the supply of Antiretroviral for the treatment of HIV and AIDs patients in certain developing countries. To issue 22,50,000 equity shares at Rs 1500/- per share aggregating to Rs 3375 mn on Preferential basis to Newbridge Capital and other investors subject to shareholders approval. To issue 'No Objection' to New Bridge Capital and other investors to enable them approach Foreign Investment Promotion Board (FIPB), to obtain their approval for purchase of 18,00,000 equity shares from the existing shareholders through a secondary sale and To convene an Extraordinary Meeting of the members of the company on January 29, 2004 for the aforesaid purpose. 2004 -Gets USFDA nod for manufacturing facility located at Jeedimetlla -Matrix Labs inks pact with India Newbridge Investments -Matrix Labs appoints Dr. C Satyanarayana as BoD 2005 -Matrix in strategic alliance with MCHEM of China - Receives US FDA approval for its Active Pharmaceutical Ingredients (APIs) manufacturing facility located at Kazipally (Unit-II), near Hyderabad. Commissioned in 2004, the facility currently manufactures anti-retrovirals (ARVs) for the treatment of HIV / AIDS. | |
![]() | |
Source : Dion Global Solutions Limited | |
![]() |
Quick Links for Matrix Laboratories
Related Searches
Matrix Laboratories Stock Price, Matrix Lab Stock Quote, Matrix Lab Results , Matrix Lab News ..
More »
Follow moneycontrol
Explore Moneycontrol
Mutual Funds
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Live Sensex | Public Sector Banks | Market Statistics | Plan Insurance | Global Market | Business News | Mutual Fund | Best Portfolio Manager | Bse Sensex | Nse Nifty | Commodities Price | Silver Price/Rate in India | Gold Price/Rate in India | Crude Oil | USD to INR | Bank Fixed Deposits | Company Fixed Deposits | Small Savings Schemes | Bonds |
Budget 2018 | Tax Calculator | RBI Credit Policy | News Archive | FAQs | Financial Glossary | Message Board | Moneybhai | Think India | History India | Latest News | IBNLive News | News in Hindi | Cricket News | Online Study Material | India News |Restaurants in Kolkata | Online Shopping in India | Amazon Kindle | Vijay Mallya | Tata Steel | Raghuram Rajan | Maruti Suzuki | American Tower Corporation | Future Retail Ltd | Nita Ambani | HDFC Bank | Indian rupee
| Rss Feeds
Site Map | About Us | Contact Us | Advertise | Bookmark | Disclaimer | Privacy Statement | Terms of Use | Careers
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.